|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
25
|
|
pubmed:dateCreated |
1991-7-3
|
|
pubmed:abstractText |
The period of neutropenia after autologous bone marrow transplantation results in substantial morbidity and mortality. The results of previous phase I-II clinical trials suggest that recombinant human granulocyte-macrophage colony-stimulating factor (rhGM-CSF) may accelerate neutrophil recovery and thereby reduce complications in patients after autologous bone marrow transplantation.
|
|
pubmed:grant |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jun
|
|
pubmed:issn |
0028-4793
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
20
|
|
pubmed:volume |
324
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
N
|
|
pubmed:pagination |
1773-8
|
|
pubmed:dateRevised |
2010-3-24
|
|
pubmed:meshHeading |
pubmed-meshheading:1903847-Adolescent,
pubmed-meshheading:1903847-Adult,
pubmed-meshheading:1903847-Bone Marrow Transplantation,
pubmed-meshheading:1903847-Child,
pubmed-meshheading:1903847-Double-Blind Method,
pubmed-meshheading:1903847-Female,
pubmed-meshheading:1903847-Granulocyte-Macrophage Colony-Stimulating Factor,
pubmed-meshheading:1903847-Humans,
pubmed-meshheading:1903847-Infection Control,
pubmed-meshheading:1903847-Leukemia,
pubmed-meshheading:1903847-Leukemia, Myeloid, Acute,
pubmed-meshheading:1903847-Leukocyte Count,
pubmed-meshheading:1903847-Lymphoma,
pubmed-meshheading:1903847-Lymphoma, Non-Hodgkin,
pubmed-meshheading:1903847-Male,
pubmed-meshheading:1903847-Middle Aged,
pubmed-meshheading:1903847-Neutropenia,
pubmed-meshheading:1903847-Postoperative Complications,
pubmed-meshheading:1903847-Precursor Cell Lymphoblastic Leukemia-Lymphoma,
pubmed-meshheading:1903847-Recombinant Proteins,
pubmed-meshheading:1903847-Transplantation, Autologous
|
|
pubmed:year |
1991
|
|
pubmed:articleTitle |
Recombinant granulocyte-macrophage colony-stimulating factor after autologous bone marrow transplantation for lymphoid cancer.
|
|
pubmed:affiliation |
Fred Hutchinson Cancer Research Center, Seattle, WA.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Research Support, U.S. Gov't, P.H.S.,
Randomized Controlled Trial
|
